Navigation Links
ev3 Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
Date:7/31/2008

PLYMOUTH, Minn., July 31 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, chief financial officer, and Julie Tracy, chief communications officer are scheduled to present at the Canaccord Adams 28th Annual Global Growth Conference on Tuesday, August 12, 2008 at 4:00 p.m. Eastern Time. The Canaccord Adams 28th Annual Global Growth Conference will be held at the Intercontinental Hotel in Boston, Massachusetts.

To access the webcast, go to the investors' section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of lower extremity vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August
2. Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference
3. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
4. American Lung Association Congratulates the U.S. House of Representatives for Passage of Historic Tobacco Legislation
5. CryoCath to Present at BMO Healthcare Conference
6. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
7. Olympian Van Dusen to Represent Body Bar Systems
8. Stryker To Present at Investor Conference
9. Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors
10. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
11. Access Granted to Present at the Collaborative Communications Summit: Health Technology Investment Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the ... series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ... been recognized for adherence to the highest standards of trauma, maternity, cancer and ... the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health platform ... by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning ... serve more consumers who are managing chronic conditions or simply want to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an ... families in and around the Cape Coral area, is embarking on a charity drive ... of Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students ... have the unique opportunity to get hands-on experience in an emergency medical simulation, ... immersive experience to gain invaluable, real-life medical skills that are critical success in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  A new study by a pair of Geisinger ... therapy to treat chronic pain is not only ineffective, ... consequences, including death. Palliative care physicians ... , M.D., authored the study which provides a review ... study was published in the December 2016 edition of ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... 2016 Mederi Therapeutics Inc . hat die behördliche Zulassung ... für gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast ... of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology: